Investing

How Will TruDoc’s $15M Funding Redefine GCC Healthcare?
Technology How Will TruDoc’s $15M Funding Redefine GCC Healthcare?

The recent announcement that TruDoc has secured a $15 million Pre-Series B funding round signifies a transformative shift in the Gulf Cooperation Council’s medical sector, moving it away from expensive, hospital-centric care toward a digitized, patient-first methodology. This strategic capital i

Can MUSC’s $111M Deal End SC’s Primary Care Shortage?
Business Can MUSC’s $111M Deal End SC’s Primary Care Shortage?

South Carolina currently faces a staggering healthcare crisis where forty-three out of forty-six counties suffer from a severe lack of primary care practitioners, leaving thousands of residents without reliable medical access. To counter this, the Medical University of South Carolina has executed a

How Is Telemedicine Shaping the European Medical Cannabis Market?
Public Policy How Is Telemedicine Shaping the European Medical Cannabis Market?

The rapid expansion of specialized digital health platforms has fundamentally altered how patients interact with the medical cannabis market across the European continent through the use of integrated technological solutions. Digital prescription platforms and cross-border physician networks now

Is Performance-Based Pricing the Future of Healthcare AI?
Technology Is Performance-Based Pricing the Future of Healthcare AI?

The traditional software licensing model that once dominated the medical technology landscape is currently undergoing a radical disintegration as hospital executives demand more than just access to tools. This fundamental realignment suggests that the era of static Software-as-a-Service (SaaS)

Atavistik Bio Raises $40M to Launch HHT Clinical Trials
Care Atavistik Bio Raises $40M to Launch HHT Clinical Trials

The medical community is closely watching the evolution of Atavistik Bio, a company leveraging a unique metabolic signaling platform to tackle diseases that have long lacked targeted solutions. Led by research originating from the University of Utah, the firm is currently transitioning into a

FDA Approves Zongertinib for HER2-Mutant Lung Cancer
Public Policy FDA Approves Zongertinib for HER2-Mutant Lung Cancer

Precision Oncology and the Evolution of Targeted Lung Cancer Therapies The landscape of thoracic oncology has shifted dramatically as pharmaceutical innovation increasingly focuses on the granular genetic drivers that dictate tumor behavior in non-small cell lung cancer. This evolution marks a

Loading

Subscribe to our weekly news digest

Keep up to date with the latest news and events

Paperplanes Paperplanes Paperplanes
Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later